FAST NEWS: 111 Inc. enters strategic supply agreement with Scrianen Pharma
The Latest: Pharmaceutical distributor 111 Inc. (YI.US) announced Tuesday that it has entered into a strategic direct supply partnership with drug developer and maker Beijing Scrianen Pharmaceutical. Looking Up: This…
Recent Articles
RELATED ARTICLES
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK - Cancer drug maker Genfleet joins Hong Kong IPO influx
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
- TCMTech fuses old with the new by mixing AI and Chinese medicine
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
- Why aim small? 51World Digital Twin sets its sights on cloning Earth
-
Bumper dividend could trigger buyout for Ping An Health
1833.HK
